Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways (2022)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-32821-z
Publication URI: http://dx.doi.org/10.1038/s41467-022-32821-z
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1